Chicago, IL, United States of America

Sherman Elias

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Illinois. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sherman Elias. Retrieved from https://idiyas.com/inventor/sherman-elias

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Sherman Elias

Introduction

Sherman Elias is an accomplished inventor based in Chicago, IL. He has made significant contributions to the field of medical science, particularly in the area of fetal cell detection.

Latest Patents

Sherman Elias holds a patent for "Antibodies against cells of fetal origin." This invention relates to antibodies that specifically bind to fetal CD36+ cells in preference to binding to maternal CD36+ cells. The methods developed using these antibodies allow for the detection and separation of fetal cells from adult biological fluids, including maternal peripheral blood.

Career Highlights

Elias is affiliated with the University of Illinois, where he continues to advance research in his field. His work has implications for prenatal diagnostics and maternal-fetal medicine.

Collaborations

One of his notable collaborators is Arun K Sharma, with whom he has worked on various research projects.

Conclusion

Sherman Elias's innovative work in developing antibodies for fetal cell detection showcases his commitment to advancing medical science and improving prenatal care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…